BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Institute of Oncology - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.bricbordeaux.com/en/
X-WR-CALDESC:Events for Bordeaux Institute of Oncology
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240831
DTEND;VALUE=DATE:20240901
DTSTAMP:20240808T135947Z
CREATED:20240806T143657Z
LAST-MODIFIED:20240808T135947Z
UID:47571-1725062400-1725148799@www.bricbordeaux.com
SUMMARY:Alpha 1-Antitrypsin deficiency - siRNA treatments - Information meeting
DESCRIPTION:Marion Bouchecareilh\, CR CNRS team 8\, is organizing an information and exchange day for patients with Alpha 1-Antitrypsin deficiency concerning siRNA treatments for the liver damage associated with this deficiency\, on Saturday August 31\, 2024 in Bordeaux (Campus Bordeaux Pey-Berland). The aim of this event\, which will be attended by a number of French experts\, is to present and explain to patients the mode of action of siRNA treatments\, the various clinical trials currently underway and their modalities\, and feedback on this type of treatment for other pathologies. The aim of this meeting is to provide an opportunity for exchange and sharing between patients\, patient associations and the various players involved in understanding and combating the symptoms associated with this deficiency. Program available at this link Hybrid format. Free but mandatory registration before August 15 at this link  Interview with Dr Marion Bouchecareilh for FilFoie\, partner of this event\, available at this link.   \nDr Marion Bouchecareilh presents the rare disease she is studying: Alpha 1-Antitrypsin deficiency\, and the ongoing Phase 3 clinical trial involving siRNA treatment of liver damage associated with this deficiency. She also takes advantage of this interview to talk about the projects she is developing concerning primary hepatopathies and cancers of the liver associated with Alpha 1-Antitrypsin deficiency. Dr Bouchecareilh is leading the latter project in partnership with Dr Samuel Amintas\, MCU-PH also in BRIC team 8.
URL:https://www.bricbordeaux.com/en/event/alpha-1-antitrypsin-deficiency-sirna-treatments-information-meeting/
LOCATION:Pôle Juridique et judiciaire de l’Université de Bordeaux\, 35 place Pey Berland\, Bordeaux\, France
CATEGORIES:Meetings,News,Scientific seminars
ATTACH;FMTTYPE=image/jpeg:https://cdn-bricbordeaux.onlc.eu/wp-content/uploads/2024/08/journee-deficit-alpha-1-antitrypsine-.jpg
END:VEVENT
END:VCALENDAR